{
    "nct_id": "NCT04410133",
    "official_title": "An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy",
    "inclusion_criteria": "1. Eastern Cooperative Oncology Group (ECOG) performance status of 0-1, or 2 if this is an acute deterioration\n2. Previous history of solid tumor brain metastasis of any origin\n3. Histopathological confirmation of the primary solid tumor or a metastatic site within 4 years\n4. Previous radiation therapy of brain metastatic lesion(s)\n5. A reference lesion considered by the site investigator to be equivocal for recurrent brain metastasis\n6. Patient requires further confirmatory diagnostic procedures to confirm brain MRI findings and is planned for biopsy/neurosurgical intervention as standard of care (SoC) or clinical follow-up as SoC\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Patients with a history of active hematological malignancy",
    "miscellaneous_criteria": ""
}